Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000080251 | SCV000112146 | benign | not specified | 2015-04-24 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000080251 | SCV000309658 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000080251 | SCV000519287 | benign | not specified | 2016-01-28 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome- |
RCV001527300 | SCV001738263 | benign | Miyoshi muscular dystrophy 1 | 2021-06-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002055160 | SCV002447922 | benign | Qualitative or quantitative defects of dysferlin | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004707918 | SCV005240150 | benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV000080251 | SCV001920062 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000080251 | SCV001951827 | benign | not specified | no assertion criteria provided | clinical testing |